lobbying_activities: 2102508
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2102508 | a31e9579-befa-4e13-8edc-29120d4b4892 | Q1 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2018 | first_quarter | MMM | H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to access to and affordability of prescription medications and inclusion of tools to fight the opioid epidemic. H.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related to access to and affordability of prescription medications and policies and resources to fight the opioid crisis in the United States. CMS regulations regarding the Medicare Part D program and the role of Prescription Drug Plans S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. H.R. 3447 - Furthering Access to Coordinated Treatment for Seniors (FACTS) Act of 2017 - Working to explain the need for safe and confidential data sharing between Medicare part A, B, and D to ensure better coordination of patient care. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-04-06T14:05:22.117000-04:00 |